Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Omnibus spending package

This article was originally published in The Gray Sheet

Executive Summary

President Clinton signs fiscal 2000 Omnibus Consolidated Appropriations Act at a White House ceremony Nov. 29. HR 3194 includes $16 bil. over five years to restore some planned BBA 1997 cuts to Medicare providers and Medicare+Choice plans. The legislation was adopted by the House Nov. 18 and the Senate on Nov. 19. In his remarks, Clinton highlighted increased investment in biomedical research, mental health and pediatric training, including a $2.3 bil. increase to $17.9 bil. for the National Institutes of Health. Clinton noted that passage of a Patients' Bill of Rights and Medicare reform, including a voluntary prescription drug benefit, are among the Administration's priorities for next year

You may also be interested in...

Coronavirus Update: Novartis Targets COVID-19 Cytokine Storm With Jakavi

Jakavi joins the likes of Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients

As China Rushes Medical Supplies To World, Quality Issues Resurface

As China is poised to supply globally medical products to fight coronavirus, a battle to banish its image of poor product quality is on.

UK Regulator Puts Energies Into COVID-19 While Other Services May Take Longer

With finite resources, the UK’s regulatory agency responsible for health care products is rapidly addressing COVID-19 medtech issues. But shifting its focus will cause delays elsewhere.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts